Alfugress 10 ER Tablet
Alfuzosin
10 mg
La Renon Healthcare Pvt. Ltd.
| Pack size | 10 Tablets |
|---|---|
| Dispensing mode | |
| Source | |
| Agent | |
| Retail Price | 95.00 AED |
Indications
Alfugress 10 ER Tablet is used for:
Benign prostatic hyperplasia (BPH)
Adult Dose
Oral
Benign prostatic hyperplasia
Adult: 2.5 mg tid. Max: 10 mg/day. 1st dose should be given before bedtime. Extended-release: 10 mg once daily.
Elderly: Initially, 2.5 mg bid. Acute urinary retention: Extended-release: 10 mg once daily to be taken from 1st day of catheterisation. Duration: 3-4 days.
Hepatic impairment: Mild to moderate: Initially, 2.5 mg daily, may increase to 2.5 mg bid according to response. Severe: Contraindicated.
Child Dose
Renal Dose
Renal Impairment Initially, 2.5 mg bid. Adjust dose according to response.
Administration
Administration Should be taken with food. Swallow whole.
Extended-Release: Should be taken with food. Take immediately after the same meal each day. Swallow whole, do not chew/crush.
Contra Indications
Severe hepatic impairment; history of postural hypotension and micturition syncope; intestinal occlusion; severe renal insufficiency; lactation.
Precautions
Elderly; hypertension; coronary insufficiency; angina (discontinue); renal or hepatic impairment. Monitor BP regularly. May affect ability to drive or operate machinery.
Pregnancy-Lactation
Pregnancy Category: B
Lactation: Not indicated for use in women
Interactions
Additive effect on QT interval prolongation when used w/ QT-prolonging drugs. Concomitant admin w/ other ?1-adrenergic blocking agents, atenolol or diltiazem may result in additive CV effects. Increased plasma alfuzosin concentrations w/ cimetidine.
Potentially Fatal: Concurrent use w/ potent CYP3A4 inhibitors (e.g. ketoconazole, itraconazole, ritonavir) increase plasma alfuzosin levels.
Adverse Effects
Side effects of Alfuzosin :
1-10%
Abdominal pain (1-2%), Back pain (1-2%), Brochitis (1-2%), Constipation (1-2%), Dizziness (5.7%), Dyspepsia (1-2%), Fatigue (2.7%), Headache (3%), Impotence (1-2%), Nausea (1-2%), Pharyngitis (1-2%), URT infection (3%), Sinusitis (1-2%), Upper respiratory infection (3%)
Mechanism of Action
Alfuzosin is a quinazoline derivative which exhibits selectivity for alpha1-adrenergic receptors in the lower urinary tract. Blockade of these adrenoreceptors causes relaxation of smooth muscle in the bladder neck and prostate, resulting in improvement in urine flow and a reduction in symptoms of benign prostatic hyperplasia (BPH).
Note
Alfugress 10 ER 10 mg Tablet manufactured by La Renon Healthcare Pvt. Ltd.. Its generic name is Alfuzosin. Alfugress 10 ER is availble in United Arab Emirates.
Farmaco UAE drug index information on Alfugress 10 ER Tablet is not intended for diagnosis, medical advice or treatment; neither intended to be a substitute for the exercise of professional judgment.
Some other brands of Alfuzosin :
Tablets / Film-coated
Xatral
2.5mg
SYNTHELABO GROUPE
Tablets / Sustained Release
XATRAL SR
5mg
SYNTHELABO GROUPE
Tablets / Prolonged Release
XATRAL XL
10mg
SYNTHELABO GROUPE
Tablets / Extended Release
URITAB XL
10mg
Tabuk Pharmaceutical Manufacturing Co.
Tablets / Prolonged Release
ALFOSIN XR
10mg
APOTEX INC.